SMi release attendee list for ADMET 2014

Share Article

The 9th annual ADMET conference will take place on the 30th June & 1st July 2014, London, UK.

ADMET | 30TH JUNE & 1ST JULY 2014, London UK


'The SMI conference looks to be a condensed but wide-ranging overview of current issues facing the ADMET scientist. I am looking forward to a good mix of ADME and Tox discussions on both small and large molecules.' David Stresser, Drug Metabolism Services

SMi's 9th annual conference on ADMET will open its door this month at The Marriott Regents Park Hotel in Central London.

Network with the following confirmed attendees:
Admescope, Astra Zeneca, Biolab Sanus Farmaceutica Ltda, Cancer Research Technology, Corning Life Sciences, Debiopharm, Eisai Pharmaceuticals, EligoChem, Galapagos NV, Genentech, GSK, Imperial College London, Ipsen Pharma, Janssen Strategic Marketing, King's College London, Lexicon Pharmaceuticals, Medicyte, MedImmune, Med-Simple, Novartis Pharma, Proximagen, Roche Pharmaceuticals, Sanofi-Aventis, Sovicell, The Research Network, TranScrip Partners, UCB, University Of Sussex, Vertex Pharmaceuticals plus many more.

This year's event will focus on key topic areas such as Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes.

The 2014 speaker line-up includes:

  •     Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  •     Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  •     Sarah Baldwin, In Vitro DMPK Manager, GSK
  •     Chris Powell, VP Safety Assessment, GSK
  •     Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  •     Richard Thompson, Principal Scientist, AstraZeneca
  •     Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  •     Adina Tocoian, Senior Clinical Pharmacologist, UCB
  •     David Fairman, Senior Clinical Pharmacokinetist, MedImmune

To view the conference agenda, visit


  •     Best Practices – Share ideas with industry leaders to identify cutting-edge developments including peptides in drug discovery, the use of label free technologies in drug development, 3D cell culture to predict hepatotoxity, computational models and evolving transporter strategies.
  •     Strategy – Aid your drug development and hear case study driven presentations from leading academia and pharmaceutical KOLS including Novo Nordisk, Medlmmune, Roche, GSK, Astra Zeneca, Imperial College London, Genetech, Novartis and Sanofi-Aventis.
  •     Industry - Learn about hot topics with unique insights into accurate human dose prediction, immunogenicity, H-bonding, cardiac safety, PBPK, pharmacokinetics, risk assessment plus much more.
  •     Regulation – Receive regulatory direction on drug transporters and obtain a comparative review of the EMA vs. FDA guidelines for immunogenicity of biologics.
  •     The Future – Look ahead into the rapidly changing field of computational biology and learn how to apply this approach to ADMET and to your own project.

Places are now filling up fast so those interested are advised to secure their seat today, please visit to book now.

For further details, please contact Sajid Goraya on email sgoraya(at)smi-online(dot)co(dot)uk or call +44 (0)20 7827 6148.

Enhancing Drug Quality by ADMET Optimisation in Discovery
30TH & 1ST JULY 2014
The Marriott Regents Park Hotel

About SMi Group
The SMi Group is a highly professional, independent and global event-production company that specializes in Business-to-Business Conferences, Workshops and Masterclasses, and online Communities. The SMi Group creates and delivers events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. For more information, please visit

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Julia Rotar
Teri Arri

Visit website